I now have very rich, comprehensive content from two authoritative textbooks. I have enough to compile a thorough answer. Let me now produce the full structured response.
Approach to Metabolic Acidosis: Causes and Management
Definition and Pathophysiology
Metabolic acidosis is defined as a primary decrease in plasma [HCO₃⁻], resulting in acidemia (arterial pH < 7.35). It arises from one of three mechanisms:
- Excessive endogenous acid production - overproducing L-lactic acid or ketoacids beyond renal capacity to excrete
- Loss of bicarbonate - from the GI tract (diarrhea) or kidney (proximal RTA)
- Impaired renal acid excretion - progressive accumulation of endogenous acids (uremia, distal RTA)
- Brenner and Rector's The Kidney, p. 91
Step 1 - Confirm Acidemia and Calculate the Anion Gap
Simultaneously obtain arterial blood gas (ABG) + serum electrolytes. The calculated [HCO₃⁻] on ABG and the measured value on electrolyte panel should agree within ±2 mmol/L; a larger discrepancy suggests a lab or sampling error.
Anion Gap (AG):
AG = Na⁺ - (Cl⁻ + HCO₃⁻)
Normal = 6-12 mmol/L (average ~10 mmol/L)
Correct for hypoalbuminemia - for each g/dL of albumin below 4.5 g/dL, add 2.5 mmol/L to the reported AG. Failure to correct can mask a high-AG acidosis in critically ill, hypoalbuminemic patients.
- Harrison's Principles of Internal Medicine 22E, p. 708
Step 2 - Classify the Metabolic Acidosis
A. High Anion Gap (AG) Metabolic Acidosis
Caused by accumulation of an unmeasured anion that consumes HCO₃⁻ while Cl⁻ remains unchanged. The "MUDPILES" / KUSMALE mnemonic captures the major causes:
| Category | Examples |
|---|
| Lactic acidosis | Type A (hypoperfusion, shock, hypoxia); Type B (metformin, sepsis, liver failure, thiamine deficiency, cyanide) |
| Ketoacidosis | Diabetic (DKA), alcoholic, starvation |
| Uremic acidosis | Acute and chronic kidney failure |
| Toxin ingestion | Ethylene glycol (anti-freeze - produces oxalic acid), Methanol (produces formic acid), Salicylates (stimulates lactate + ketones), Propylene glycol, Pyroglutamic acid (5-oxoproline) |
- Harrison's Principles of Internal Medicine 22E, Table 58-4
Initial screening of high-AG acidosis includes:
- Drug/toxin history + respiratory alkalosis on ABG (salicylates)
- History of diabetes (DKA)
- Alcohol abuse + β-hydroxybutyrate level (alcoholic ketoacidosis)
- Baseline BUN/Cr rise (uremic acidosis)
- Urine oxalate crystals (ethylene glycol)
- Clinical settings of elevated lactate (hypotension, sepsis, bowel ischemia, seizures)
B. Normal Anion Gap (Hyperchloremic) Metabolic Acidosis
HCO₃⁻ is effectively replaced by Cl⁻ - the AG does not change. Two major categories:
1. GI Bicarbonate Loss
| Cause | Notes |
|---|
| Diarrhea | Most common; HCO₃⁻ and potential HCO₃⁻ (butyrate, propionate) lost in stool; hypokalemia common |
| External pancreatic/small bowel drainage | Pancreatic fluid is HCO₃⁻-rich |
| Uterosigmoidostomy, jejunal loop | Colonic mucosa exchanges Cl⁻ for HCO₃⁻ |
| Drugs | Calcium chloride, cholestyramine (bile acid diarrhea), magnesium sulfate |
2. Renal Tubular Acidosis (RTA) and Related Causes
Type 1 (Classical Distal RTA) - hypokalemia
- Impaired H⁺ secretion in the collecting duct
- Urine pH persistently >5.5 even in acidosis
- Causes: Sjögren's syndrome, SLE, amphotericin B, lithium, obstructive uropathy
Type 2 (Proximal RTA) - hypokalemia
- Impaired HCO₃⁻ reabsorption in the proximal tubule
- Urine pH <5.5 (at steady state); fractional excretion of HCO₃⁻ >15-20% when plasma HCO₃⁻ is raised
- Associated with Fanconi syndrome (cystinosis, Lowe's, multiple myeloma, Wilson's, heavy metals)
- Drugs: acetazolamide, topiramate, ifosfamide
Type 4 RTA (Hyperkalemic distal) - hyperkalemia
- Hypoaldosteronism or aldosterone resistance → impaired NH₄⁺ excretion
- Causes: diabetic nephropathy (low renin/aldosterone), ACE inhibitors, ARBs, K⁺-sparing diuretics (amiloride, spironolactone), trimethoprim, NSAIDs, cyclosporine, tacrolimus, Addison's disease
Type 3 RTA - carbonic anhydrase II deficiency; mixed proximal + distal features
3. Other Normal-AG Causes
-
Acid loads: ammonium chloride, hyperalimentation
-
Dilution acidosis: rapid large-volume saline administration
-
Loss of potential HCO₃⁻: ketosis with ketone excretion (not all anions reabsorbed)
-
Hippurate accumulation (toluene inhalation - can be mixed)
-
Early/mild CKD (stage 3-4)
-
Brenner and Rector's The Kidney, Table 16.6
Step 3 - Assess Compensation (Winter's Formula)
For metabolic acidosis, the expected compensatory respiratory response is:
Expected PaCO₂ = (1.5 × [HCO₃⁻]) + 8 ± 2 (Winter's formula)
- If measured PaCO₂ > expected → superimposed respiratory acidosis
- If measured PaCO₂ < expected → superimposed respiratory alkalosis
Step 4 - Delta-Delta Ratio (High-AG Acidosis Only)
For high-AG acidosis, compare ΔAG vs ΔHCO₃⁻ to detect a mixed disorder:
ΔAG = (patient AG - 10) | ΔHCO₃⁻ = (25 - patient HCO₃⁻)
| Ratio ΔAG/ΔHCO₃⁻ | Interpretation |
|---|
| ~1:1 | Pure high-AG metabolic acidosis |
| >2 | Concurrent metabolic alkalosis (HCO₃⁻ higher than expected) |
| <1 | Concurrent normal-AG acidosis (HCO₃⁻ lower than expected) |
Examples from Harrison's: uremia with vomiting (high-AG + metabolic alkalosis); diarrhea + lactic acidosis (mixed high-AG + normal-AG).
Step 5 - Urine Anion Gap (for Normal-AG Acidosis)
Used to distinguish GI from renal cause of non-AG acidosis:
UAG = Urine (Na⁺ + K⁺) - Urine Cl⁻
| UAG | Interpretation |
|---|
| Negative (Cl⁻ > Na⁺ + K⁺) | Appropriate renal NH₄⁺ excretion → GI bicarbonate loss (diarrhea) |
| Positive (Cl⁻ < Na⁺ + K⁺) | Impaired NH₄⁺ excretion → Renal cause (RTA) |
Urine pH: distal RTA urine pH >5.5 even in acidosis; proximal RTA urine pH <5.5 at baseline but rises with alkali loading.
Management
General Principles
Treat the underlying cause first - this is the cornerstone.
- DKA: insulin + fluids + electrolyte replacement
- Lactic acidosis: restore perfusion, treat sepsis, stop offending agents (metformin)
- Toxic alcohol ingestion: fomepizole (alcohol dehydrogenase inhibitor), dialysis
- Diarrhea: oral rehydration, treat underlying infection
Alkali (Bicarbonate) Therapy
Alkali therapy should be reserved for severe acidemia unless there is no "potential HCO₃⁻" in plasma.
When to give NaHCO₃:
- Non-AG (hyperchloremic) acidosis where underlying cause cannot be rapidly reversed
- Uremic acidosis (target plasma HCO₃⁻ ≥22 mmol/L)
- Severe acidemia with non-metabolizable anions (uremia, toxin ingestion)
- DKA: only if pH <7.00 and/or evidence of shock
Target in DKA: NaHCO₃ 50 mEq in 300 mL saline over 30-45 min; target HCO₃⁻ 10-12 mmol/L and pH ~7.20 (do NOT normalize)
Why not give NaHCO₃ freely?
- In DKA and lactic acidosis, the accumulated anions (lactate, ketones) are metabolizable - when the underlying cause is treated, they regenerate HCO₃⁻ endogenously ("potential HCO₃⁻")
- Risk of overshoot alkalosis, hypokalemia (once urine output resumes), worsening intracellular acidosis, and paradoxical CSF acidosis
CKD/chronic non-AG acidosis: oral NaHCO₃ tablets or Shohl's solution; target HCO₃⁻ = 22 mmol/L. Avoid overcorrection.
- Harrison's Principles of Internal Medicine 22E, p. 751-752
RTA-Specific Management
| Type | Treatment |
|---|
| Type 1 (Distal) | NaHCO₃ (1-2 mEq/kg/day); citrate solutions; potassium supplementation; treat underlying cause |
| Type 2 (Proximal) | Large doses of alkali needed (5-15 mEq/kg/day); hypokalemia must be corrected with K⁺ supplements before or alongside alkali (alkali worsens kaliuresis); thiazide diuretics (reduce volume → increase proximal reabsorption) |
| Type 4 | Fludrocortisone (if mineralocorticoid deficiency); dietary K⁺ restriction; furosemide; discontinue offending drugs |
Renal Replacement Therapy (Dialysis)
Indicated when:
- Intractable metabolic acidosis not responding to bicarbonate
- Severe electrolyte abnormalities (hyperkalemia)
- Fluid overload
- Toxic alcohol ingestion (ethylene glycol, methanol) - removes toxic metabolites
Novel Therapy
Veverimer - a novel GI acid-sequestrant (not absorbed) studied in CKD-related metabolic acidosis; a
2025 systematic review (PMID 39277780) confirmed that dietary and pharmacologic interventions targeting metabolic acidosis in CKD improve GFR and physical function.
A 2026
review on acute metabolic acidosis treatment (PMID 41328521) addresses the ongoing debate around NaHCO₃ use in critically ill patients (including evidence from BICAR-ICU trial).
Quick Diagnostic Algorithm Summary
Low pH + Low HCO₃⁻ → Metabolic Acidosis confirmed
↓
Calculate Anion Gap (correct for albumin)
↓
┌─────────────────────────┬──────────────────────────────┐
│ HIGH AG (>12) │ NORMAL AG (8-12) │
│ MUDPILES: │ Check UAG: │
│ - Lactic acidosis │ Negative → GI loss │
│ - DKA/AKA/Starvation │ (diarrhea, fistula) │
│ - Uremia │ Positive → RTA │
│ - Toxins (EG, MeOH, │ + Urine pH: │
│ ASA, propylene │ >5.5 → Type 1 or 4 RTA │
│ glycol, 5-oxoproline)│ <5.5 → Type 2 RTA │
└─────────────────────────┴──────────────────────────────┘
↓
Check Delta-Delta (high AG) - mixed disorder?
↓
Winter's formula - respiratory compensation appropriate?
Key Clinical Pearls
- Always correct AG for albumin - a "normal" AG in a hypoalbuminemic ICU patient may actually be elevated
- Lactic acidosis is the most common cause of high-AG acidosis in hospitalized patients; check lactate early
- Salicylate toxicity classically presents with mixed high-AG metabolic acidosis + respiratory alkalosis (salicylates directly stimulate the respiratory center)
- Ethylene glycol - look for osmolar gap + oxalate crystalluria + renal failure
- Type 4 RTA is the most common RTA in clinical practice (diabetic nephropathy + hypoaldosteronism)
- DKA can present as normal-AG acidosis early when urinary ketone excretion is rapid - high-AG develops once ketonuria catches up
- Overcorrection of metabolic acidosis with NaHCO₃ risks: rebound alkalosis, hypokalemia, hypocalcemia (tetany), and worsening of intracellular acidosis
Sources: Harrison's Principles of Internal Medicine 22E (2025); Brenner and Rector's The Kidney; Roberts and Hedges' Clinical Procedures in Emergency Medicine